Featured Research

from universities, journals, and other organizations

Clot-busting enzymes are working two jobs

Date:
October 4, 2012
Source:
Monash University
Summary:
The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.

The body's blood clot-busting enzymes are much busier than previously imagined, with new research showing that they also dispose of every cell that dies prematurely from disease or trauma.

In research published October 4 in Cell Reports, scientists from Monash University have demonstrated for the first time the enzyme t-PA, which plays a vital role in the removal of blood clots, is also a major player in the removal of necrotic, or dead, cells.

Necrosis occurs when cells in living tissue die prematurely due to external stress or injury. The body's system for removing waste associated with necrotic cell removal was not, until now, well understood.

Professor Robert Medcalf and Dr Andre Samson, of the University's Australian Centre for Blood Diseases (ACBD), led the research with Professor Stephen Bottomley of the Monash Department of Biochemisty and Molecular Biology.

The research team found that in the late stages of death, the injured cell undergoes a restructure and takes on a form not unlike a blood clot, to prepare for efficient removal from the body. This process had never been described before.

Professor Medcalf said the blood clot-like structure allowed the damaged cells to be recognised and removed by t-PA and its enzymatic waste disposal team.

"It's exactly the same principle as the formation and removal of a blood clot," Professor Medcalf said.

"In the process of a cell dying it goes through this unique form of aggregation to keep all the intracellular debris localised. Then, it can be taken out in an orderly fashion by the blood clot-busting enzyme system without causing damage to the body."

The researchers were studying brain tissue when they made the discovery, but have shown that the same process applies to every cell in the body.

"It's very efficient. Instead of doubling up, the body is using the same disposal system to eliminate a variety of unwanted waste products, be they dead cells or blood clots that have served their purpose," Professor Medcalf said.

"What this means is that t-PA and its team of enzymes recognises waste through structure or shape, not by the specific proteins involved."

The findings shed further light on the function and therapeutic uses of t-PA, which is used in the treatment of stroke and heart attack.

Researchers from Alfred Health and the Ludwig Institute for Cancer Researchers also collaborated on the study, which was funded by the National Health and Medical Research Council of Australia.


Story Source:

The above story is based on materials provided by Monash University. Note: Materials may be edited for content and length.


Journal Reference:

  1. AndreL. Samson, AnjaS. Knaupp, Maithili Sashindranath, RachaelJ. Borg, AmandaE.-L. Au, ElisaJ. Cops, HelenM. Saunders, StephenH. Cody, CatrionaA. McLean, CameronJ. Nowell, VictoriaA. Hughes, StephenP. Bottomley, RobertL. Medcalf. Nucleocytoplasmic Coagulation: An Injury-Induced Aggregation Event that Disulfide Crosslinks Proteins and Facilitates Their Removal by Plasmin. Cell Reports, 2012; DOI: 10.1016/j.celrep.2012.08.026

Cite This Page:

Monash University. "Clot-busting enzymes are working two jobs." ScienceDaily. ScienceDaily, 4 October 2012. <www.sciencedaily.com/releases/2012/10/121004121544.htm>.
Monash University. (2012, October 4). Clot-busting enzymes are working two jobs. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/10/121004121544.htm
Monash University. "Clot-busting enzymes are working two jobs." ScienceDaily. www.sciencedaily.com/releases/2012/10/121004121544.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins